HFA
RPTX

Hoover Financial Advisors’s Repare Therapeutics RPTX Stock Holding History

Hoover Financial Advisors’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$10K Buy
+322
New +$10.5K ﹤0.01% 478

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Hoover Financial Advisors's RPTX Position: Q2 2021 in Review

Hoover Financial Advisors opened a new position in Repare Therapeutics (RPTX) in Q2 2021: 322 shares worth $10K. The stake represents ﹤0.01% of the portfolio and ranks #478 among its holdings.

61 funds tracked by Wall St. Rank hold RPTX as of Q2 2021.

  • Hoover Financial Advisors held 322 shares of Repare Therapeutics worth $10K as of Q2 2021.
  • Repare Therapeutics was a new Hoover Financial Advisors position in Q2 2021.
  • Repare Therapeutics made up ﹤0.01% of Hoover Financial Advisors's portfolio in Q2 2021, its #478 holding.
  • 61 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.